4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-054626
President and CEO sold 3,606 shares at $0.92 ($3,319)
From the SEC's structured data for this filing
Trades in this filing
Paulson Richard A. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-06 | Sale : show line 1 in the form | −3,606 | $0.92 | $3,319 | 791,201 | D |
| Open-market sales · 3,606 sh · avg $0.92 · $3,319 | ||||||
Loading xslF345X05/doc4.xml…